Safety organizations across biopharma are under significant cost pressure and substantial regulatory scrutiny. Thriving in the current safety landscape requires a new approach to address these new pressures. At Quintiles, our Lifecycle Safety group has evolved to meet the current needs of the market to not only address these new pressures, but to help you turn them into a competitive advantage.